迪威尔(688377) - 2024 Q1 - 季度财报

Financial Performance - In Q1 2024, the company's operating revenue was CNY 286,364,411.58, representing a year-on-year increase of 5.78%[15] - The net profit attributable to shareholders was CNY 28,219,443.78, showing a decrease of 7.37% compared to the previous year[15] - The basic and diluted earnings per share were both CNY 0.15, a decrease of 6.25% year-on-year[5] - Total operating revenue for Q1 2024 reached ¥286,364,411.58, an increase of 5.99% compared to ¥270,722,117.25 in Q1 2023[26] - Net profit for Q1 2024 was ¥28,219,443.78, a decrease of 7.39% from ¥30,465,615.40 in Q1 2023[28] - Basic earnings per share for Q1 2024 was ¥0.15, down from ¥0.16 in Q1 2023[29] Assets and Liabilities - The total assets at the end of the reporting period were CNY 2,486,099,088.65, down 1.54% from the end of the previous year[5] - The total assets and equity of the company amounted to ¥2,486,099,088.65 and ¥1,777,415,208.18 respectively in Q1 2024, compared to ¥2,524,982,807.85 and ¥1,742,492,999.37 in Q1 2023[26] - Total liabilities decreased from 782.49 million to 708.68 million, a reduction of approximately 9.45%[48] - Current liabilities decreased from 726.29 million to 652.83 million, a decrease of about 10.09%[48] - Total assets decreased from 2.52 billion to 2.49 billion, a decline of approximately 1.32%[51] Cash Flow - The net cash flow from operating activities was CNY -40,415,799.04, reflecting a decline of 172.97%[5] - Cash flow from operating activities decreased by 17.97% to ¥282,163,053.72 in Q1 2024 from ¥344,232,736.62 in Q1 2023[30] - Cash flow from operating activities showed a net outflow of 40.42 million, compared to a net inflow of 55.39 million in the previous period[48] - Cash flow from investing activities resulted in a net outflow of 43.01 million, improving from a net outflow of 121.48 million in the previous period[48] - The company reported a cash outflow of 183.91 million in investing activities, compared to 673.17 million in the previous period[48] Research and Development - The company's R&D investment totaled CNY 9,481,376.00, accounting for 3.31% of operating revenue, a decrease of 0.17 percentage points[5] - Research and development expenses remained stable at ¥9,481,376.00 in Q1 2024, slightly up from ¥9,419,167.11 in Q1 2023[26] Shareholder Information - The total equity attributable to shareholders increased by 2.00% to CNY 1,777,415,208.18 compared to the end of the previous year[5] - The number of ordinary shareholders at the end of the reporting period was 5,767[8] Other Financial Metrics - The weighted average return on equity was 1.60%, a decrease of 0.26 percentage points year-on-year[5] - The company experienced a decrease in cash received from sales, which was ¥243,418,864.45 in Q1 2024, down from ¥318,172,841.55 in Q1 2023[30] - The company’s investment income for Q1 2024 was ¥801,924.10, a decrease from ¥1,676,680.35 in Q1 2023[26] - Cash and cash equivalents at the end of the period were 119.69 million, down from 193.85 million[49] - Inventory decreased from 432.32 million to 419.21 million, a reduction of about 3.00%[51] - Long-term borrowings remained stable at approximately 28.37 million[48] - The company received government subsidies amounting to CNY 3,252,870.56 during the reporting period[5]